Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
RSC Chemical Biology|January 8, 2025
Induced cell phenotype activity recording of DNA-tagged ligandsPhilipp N Sander, Jared T Gillen Miller, Luke L Lairson
Annual Review of Pharmacology and Toxicology|January 9, 2013
Small molecule-based approaches to adult stem cell therapiesLuke L Lairson, Costas A Lyssiotis, Shoutian Zhu, et al.
Molecular & Cellular Oncology|September 22, 2016
A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenaseEdouard Mullarky, Luke L Lairson, Lewis C Cantley, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 12, 2021
Towards an Understanding of the Molecular Mechanisms of Variable Unnatural Base-Pair Behavior: A Biophysical Analysis of dNaM-dTPT3Rebekah J Karadeema, Sydney E Morris, Luke L Lairson, et al.
Bioorganic & Medicinal Chemistry Letters|July 31, 2021
Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screenRyan J Shirey, Lewis D Turner, Luke L Lairson, et al.
Nature Chemical Biology|October 24, 2006
Using substrate engineering to harness enzymatic promiscuity and expand biological catalysisLuke L Lairson, Andrew G Watts, Warren W Wakarchuk, et al.
Plos One|August 27, 2013
Normal CFTR inhibits epidermal growth factor receptor-dependent pro-inflammatory chemokine production in human airway epithelial cellsSuil Kim, Brittney A Beyer, Courtney Lewis, et al.
Cell Chemical Biology|October 28, 2020
HSP90 Inhibition Enhances Cancer Immunotherapy by Modulating the Surface Expression of Multiple Immune Checkpoint ProteinsReza Beheshti Zavareh, Stephan H Spangenberg, Ashley Woods, et al.
ACS Chemical Biology|August 14, 2015
A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in CancerMichael J Bollong, Hwayoung Yun, Lance Sherwood, et al.
Angewandte Chemie (International Ed. in English)|December 25, 2010
Chemical control of stem cell fate and developmental potentialCostas A Lyssiotis, Luke L Lairson, Anthony E Boitano, et al.
Pageof 7